Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parkhurst

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Cancer Immunology, Immunotherapy : CII|June 19, 2025
Clinical factors associated with growth and neoantigen reactivity of tumor infiltrating lymphocytes from metastatic epithelial cancersAlexandra M Gustafson, Aaron J Dinerman, Kyle J Hitscherich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Clinical Investigation|February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancersParisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Nature Chemistry|May 23, 2014
A transferable model for singlet-fission kineticsShane R Yost, Jiye Lee, Mark W B Wilson, et al.
Radiation Research|June 4, 2021
Ketogenic Diet with Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma: Preclinical and Phase 1 Trial ResultsDaniel C Ma, Carryn M Anderson, Samuel N Rodman, et al.
Nature Medicine|March 21, 1998
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Cancer Cell|April 22, 2022
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersKen-Ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|June 19, 2025
Clinical factors associated with growth and neoantigen reactivity of tumor infiltrating lymphocytes from metastatic epithelial cancersAlexandra M Gustafson, Aaron J Dinerman, Kyle J Hitscherich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Clinical Investigation|February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancersParisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Nature Chemistry|May 23, 2014
A transferable model for singlet-fission kineticsShane R Yost, Jiye Lee, Mark W B Wilson, et al.
Radiation Research|June 4, 2021
Ketogenic Diet with Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma: Preclinical and Phase 1 Trial ResultsDaniel C Ma, Carryn M Anderson, Samuel N Rodman, et al.
Nature Medicine|March 21, 1998
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Cancer Cell|April 22, 2022
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersKen-Ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, et al.
Pageof 13